Authorised Therapeutic use (Phase IV) Patients undergoing lumbar arthrodesis

Evaluation of the postoperative analgesic efficacy of erector spinae plane block in lumbar spinal surgery: a prospective randomized double-blind study

EU CTIS ID: 2023-504204-28-00

What this study is testing

Post-operative morphine consumption after lumbar arthrodesis with and without erector spinae plane block

  • Therapeutic use (Phase IV)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • All genders aged from 18 to 85 years old
  • ASA 1 or 2
  • Scheduled for lumbar arthrodesis surgery 1 to 3 levels

You likely can't join if

  • A BMI <18 or > 35 or weight < 50kg
  • Kidney or liver failure
  • Uncontrolled hypertension at home or requiring more than 2 anti-hypertensive treatments
  • Minimally invasive surgery with unilateral approach, percutaneous or without laminectomy
  • Allergy to one or more of the medications used in the study
  • Chronic pain (chronic medication and/or presence of a neurostimulator), fibromyalgia, psychiatric disorders, alcoholism and/or chronic use of strong opioids (considered chronic if taking a strong opioid on a daily basis for > 1 week) preoperatively
See the full eligibility criteria
Who can join
  • All genders aged from 18 to 85 years old
  • ASA 1 or 2
  • Scheduled for lumbar arthrodesis surgery 1 to 3 levels
What rules you out
  • A BMI <18 or > 35 or weight < 50kg
  • Kidney or liver failure
  • Uncontrolled hypertension at home or requiring more than 2 anti-hypertensive treatments
  • Minimally invasive surgery with unilateral approach, percutaneous or without laminectomy
  • Allergy to one or more of the medications used in the study
  • Chronic pain (chronic medication and/or presence of a neurostimulator), fibromyalgia, psychiatric disorders, alcoholism and/or chronic use of strong opioids (considered chronic if taking a strong opioid on a daily basis for > 1 week) preoperatively
  • A contraindication to a loco-regional anesthesia technique
  • Refusal of consent by the patient

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.